Bioregenx (BRGX) Interest & Investment Income (2022 - 2023)

Bioregenx's (BRGX) quarterly Interest & Investment Income came in at -$100.0 in Q4 2023, up 99.8% quarter-over-quarter from -$50800.0 in Q3 2023.

Bioregenx (BRGX) Interest & Investment Income (2022 - 2023) Analysis & Trends

Bioregenx's Interest & Investment Income history runs 2 years deep, the most recent figure standing at -$100.0 for Q4 2023.

On a quarterly basis, Interest & Investment Income changed N/A year-over-year to -$100.0 in Q4 2023; TTM through Dec 2023 was -$20900.0, a 46.41% increase from a year earlier, with the FY2023 full-year figure at -$20900.0, up 46.41% from the prior year.
Interest & Investment Income advanced to -$100.0 in Q4 2023 per BRGX's latest filing, from -$50800.0 in the prior quarter.
Across five years, Interest & Investment Income topped out at $21000.0 in Q1 2023 and bottomed at -$79400.0 in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int & Inv Inc (Qtr)
1	Veeva Systems	31.81 Bn	24.49 Bn	662.02 Mn	-27.45 Mn
2	BrightSpring Health Services	14.76 Bn	13.86 Bn	482.22 Mn	-
3	Healthequity	8.36 Bn	8.10 Bn	256.31 Mn	-
4	Hinge Health	5.91 Bn	5.60 Bn	154.23 Mn	-328,000.00
5	10x Genomics	5.89 Bn	5.35 Bn	106.18 Mn	5.01 Mn
6	MiniMed	4.45 Bn	4.16 Bn	480.00 Mn	-
7	Waystar Holding	4.41 Bn	4.35 Bn	216.84 Mn	-
8	Doximity	3.93 Bn	3.18 Bn	125.97 Mn	-
9	Privia Health	3.10 Bn	2.68 Bn	-	-
10	Bioregenx	9.69 Mn	9.65 Mn	348,288.00	-

Download Data